Table:
begin	end	state
1	40	signal peptide
41	55	non-cytoplasmic
56	80	transmembrane
81	135	cytoplasmic
136	157	transmembrane
158	173	non-cytoplasmic
174	196	transmembrane
197	226	cytoplasmic
227	245	transmembrane
246	249	non-cytoplasmic
250	267	transmembrane
268	279	cytoplasmic
280	304	transmembrane
305	318	non-cytoplasmic
319	338	transmembrane
339	342	cytoplasmic
343	360	transmembrane
361	372	non-cytoplasmic
373	394	transmembrane
395	405	cytoplasmic
406	427	transmembrane
428	428	non-cytoplasmic

Input:
>Pf6N2E2_1038
MLIFLSYAMIASFMYLIMSKRLSPLVALLLVPIVFGCLSGFTTQLGGMMYDGIKMLAPTG
IMLTFAILYFCMMTDAGLFNPLIKVLLRLVKGDPRKIVIGTAVLGLCVGLDGDGATTYII
ATAAFLPIYRLTGIRLQVMATVLLMAIGVMNILPWAGPFSRAASAMHVDITELFLEMVPV
MIAGGVWVIFAAWWLGRMEYRRLGLIAVSEDEVLKGYAHIRLSDPKFLLNVVLTVALISC
MMLNLMPLPILFMVAFGLACLVNFPTLKQQKEVIARHADNVMAVTLLIFAAGIFVGIMGG
TGMIKAISDNLITLLPQQAGHYMSVITALLSMPFTYVLTNDAFYFGVLPILAETAAHYGI
GPNEMAIASLIGQPVHLLSPLVASTYLLCGLLDIDYGDNQRVSLKWTFGTVIVMLFAAIA
IGAITVVN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server